This textbook is a clear and accessible introduction to the scientific and clinical aspects of the creation, development and administration of drugs or drug regimens used in the treatment of cancer. Unique in its approach, this book enables the student to gain an understanding of the pathological, physiological and molecular processes governing malignancy, whilst also introducing the role of health professionals and scientists in the research and treatment of cancer. The book consolidates all the essential information necessary for a full understanding of cancer chemotherapy, providing an informative, inexpensive and up-to-date coverage of the subject aimed at an undergraduate level readership. Key Features: Incorporates numerous diagrams, tables and illustrations to aid understanding. Examines key pharmacological and pharmaceutical issues such as dosing, toxicity and preparation of anti-cancer drugs. Includes a key chapter of practice essay questions to ease revision. Comprehensive coverage of drugs currently in pre-clinical and clinical development. An indispensable text for undergraduate students studying pharmacy and medicine as well as those doing courses such as molecular biology, biomedical sciences and pharmacology which cover aspects of oncology.
Cell Wars: An Oral History of Cancer Today will challenge your assumptions about how a cancer diagnosis and treatment are made in the United States in the early twenty-first century. It takes an uncomfortable subject into the realm of public discussion in ways our parents’ generation would never consider. Cancer affects all families, rich or poor. Through the collective voices of over 150 patients and medical professionals interviewed, we learn how we can reduce anxiety with this subject by modeling those who are coping well with this chronic illness. Treating cancer must be both a clinical and psychological protocol—body and head. Today more people live a quality life through advanced treatments and new discoveries. The voices in Cell Wars are both compelling and timely.
Inositol and its phosphates are ubiquitous across most life forms, wherein they play important roles in cellular integrity and functions such as signal transduction, DNA damage repair ion transport and mRNA transport. This reference details the biochemistry and industrial applications of inositol and its phosphate derivatives. Topics covered in this book include the use of inositol and its hexaphosphate (IP6) for numerous health benefits – as antioxidants, as an anti-cancer drug, for the management of atherosclerosis, diabetes, osteoporosis, Alzheimer’s disease, sickle cell anemia, and even in fighting tooth decay. Readers will also learn about Industrial applications of Inositol including preservation of food and wine, nanotechnology, lithium ion battery, fuel cell technology etc. Inositol & its Phosphates: Basic Science to Practical Applications is a valuable reference for any researcher or aspiring biomedical professional seeking to know more about this fascinating metabolite.
This book should be read as a requirement for anyone diagnosed with cancer. It will serve as a tremendous practical guide for cancer patients and their families. —Thomas N. Seyfried, Professor of biology at Boston College and author of Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer. This book is a “must read” for every adult as cancer remains our greatest enemy. If you have experience with cancer, via a family member or friend, once you start reading this book, it will be hard to put down. —Peter L. Pedersen, Professor of Biological Chemistry & Oncology, Johns Hopkins University. Dr. Westman’s personal experience with cancer led him to extensively research the state of cancer care. Strengthening the body’s own immune system to prevent and control cancer has shown very promising results, but it is largely ignored by mainstream cancer research and treatment. If you care about winning the war on cancer, this book will motivate you to advocate for more funding for this line of research. —Stephen L. Swanson, Past Chair of the Board of Directors of the American Cancer Society Dr. Westman’s book is amazing, creative, innovative, different, stimulating and outstanding. —Bharat B. Aggarwal, Professor of Cancer Research, University of Texas M. D. Anderson Cancer Center.
In recent years, great strides have been made in the field of cancer research. Now, with Basic Science of Cancer, a range of interrelated topics such as tumor suppressor genes, apoptosis, transcriptional regulation, pharmacology of anticancer drugs, cytogenetic techniques, oncogenes, and signal transduction are thoroughly addressed. Written for oncologists and healthcare professionals, this new comprehensive reference also discusses modern research techniques used to investigate the molecular etiology and treatment of human cancer. Topics are described using nontechnical terms. Together, complete reference listings and over 200 illustrations provide an extensive, yet introductory, look into the complex field of cancer.
Publisher: Karger Medical and Scientific Publishers
Outlining the complex interaction between the two phenomena Cancer is clearly an age-related disease. Recent research in both aging and cancer has demonstrated the complex interaction between the two phenomena. This affects a wide spectrum of research and practice, anywhere from basic research to health care organization. Core examples of these close associations are addressed in this book. Starting with basic research, the first chapters cover cancer development, mTOR inhibition, senescent cells altering the tumor microenvironment, and immune senescence affecting cancer vaccine response. Taking into account the multidisciplinarity of geriatric oncology, several chapters focus on geriatric and oncologic aspects in patient assessment, treatment options, nursing and exercise programs. The book is rounded off by a discussion on the impact of the metabolic syndrome illustrating the interactions between comorbidity and cancer and a chapter on frailty. This book provides the reader with insights that will hopefully foster his or her reflection in their own research and practice to further the development of this most exciting field. Given the aging of the population worldwide and the high prevalence of cancer, it is essential reading not only for oncologists and geriatricians but for all health practitioners.
In this first authoritative overview on modern cancer chemotherapy 121 international specialists have contributed their experience and recent data for what is likely to become the gold standard in the field. The authors summarize knowledge gained over the past decade, from basic concepts to successful applications in the clinic, covering active and passive targeting strategies as well as tissue-specific approaches. All current and future targeted delivery systems are discussed, from ligand-based to antibody-based polymer-based systems, right up to micro- and nanoparticulate systems. A special section covers the delivery of nucleic acid therapeutics, such as siRNA, miRNA and antisense nucleotides. In each case, a description of the basic technique is followed by a discussion of the latest preclinical and clinical developments in the field. By virtue of its clear and didactic structure, rich illustrative material and summary chapters, this handbook and ready reference enables the efficient transfer of knowledge between different disciplines, from basic research to the clinician and vice versa. It is equally well suited for professionals, researchers and students in medical oncology and cancer biology, and is also excellent for teaching medical students the foundations of 21st century cancer chemotherapy.
This volume will cover a series of reviews on stem cells including adult and embryonic stem cells. Speakers were invited to present these talks during the Stem Cell Symposia in fall of 2010, in Samsun, Turkey. Unique aspect of this volume is that it brings a multidisciplinary aspect of stem cells extracted from a symposium.
Immunity, Cancer, and Chemotherapy focuses on the interference of drugs on antibody response and transplantation immunity. The selection first offers information on the effects of immunosuppressive drugs on cellular changes after antigenic stimulation and specialized cell function in the lymphoid and reticuloendothelial cell series. Topics include effects of immunosuppressive drugs on the sensitization process; cellular changes in lymphoid tissue following sensitization; and demonstration of differences in antigen handling among cells of the reticuloendothelial system. The text also takes a look at allogeneic inhibition and its possible relation to cell-bound immunity in vitro and the effects of immunosuppressive drugs at various stages of differentiation of immunologically competent cells. The publication examines a study of antibody-containing cells in the course of immunization and cellular differentiation during immune responses studied with electron microscope and radioautography. The text also elaborates on ambiguity in the translation of genetic code into proteins, induced by aminoglycoside antibiotics and immunosuppressive agents and cellular kinetics of immune response. The selection is a dependable source of information for readers interested in effects of drugs on antibody response and transplantation immunity.
This issue of the Surgical Oncology Clinics of North America, Guest Edited by Dr. Jesus Esquivel, will focus on the current status and future directions of the treatment of the most common peritoneal surface malignancies: appendix cancer, colorectal cancer, ovarian cancer, gastric cancer, and peritoneal mesothelioma. This issue will also outline some of the most common issues that arise regarding cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), such as pharmacokinetic rationale of heat and intraperitoneal chemotherapy, HIPEC techniques and safety considerations, how to start a peritoneal surface malignancy program, anesthesia considerations during cytoreductive surgery and HIPEC, patient selection for cytoreductive surgery and HIPEC, and the role of dystemic chemotherapy in the management of peritoneal surface malignancies of appendiceal and colorectal origin.